Ledger.Open graph →
SEC Form D · filed February 24, 2025

Newleos Therapeutics, Inc

Offering
$93.4M
Sold
$93.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Donabedian · Concord, MAExec · DirectorRobert Hadfield · Boston, MAExecChristoph Westphal · Boston, MADirectorMing Cheah · Boston, MADirectorRaymond Camahort · SAN FRANCISCO, CADirectorJohn Mccabe · Boston, MAExecDavid Donabedian · Ayer, MAExec · DirectorRobert Hadfield · Boston, MAExecChristoph Westphal · Boston, MADirectorMing Cheah · Boston, MADirectorRaymond Camahort · SAN FRANCISCO, CADirectorJohn Mccabe · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗